Stocks News

LAST PRICE
0.2075
TODAY'S CHANGE (%)
Trending Down-0.0049 (-2.3070%)

Bid / Lots
0.2075/ 66
Ask / Lots
0.2100/ 3
Open / Previous Close
0.2099 / 0.2124
Day Range
Low 0.1960
High 0.2150
52 Week Range
Low 0.1852
High 1.7900
Volume
3,638,274
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 12, 2024
- Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test, from 9:54AM ET on Tuesday Nov 12, 2024 by MT Newswires
  9:54AM ET on Tuesday Nov 12, 2024 by MT Newswires
  Companies Mentioned: TMO, MYNZ
  09:54 AM EST, 11/12/2024 (MT Newswires) -- Mainz Biomed N.V (MYNZ) said Tuesday it has partnered with Thermo Fisher Scientific (TMO) to develop a colorectal cancer screening test. Financial details of the partnership were not disclosed. Mainz said t...
- Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones
  Companies Mentioned: TMO, MYNZ
  
  Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets
  
  BERKELEY, Calif. and MAINZ, Germany, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced a collaborative agreement with Thermo Fisher Scientific Inc. (NYSE: TMO), through its subsidiary Life Technologies Corporation ("Thermo Fisher"), a world leader in supplying life sciences solutions and services.

Today
- NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance, from 15 hours ago by Dow Jones
  15 hours ago by Dow Jones
  Companies Mentioned: NIVF
Yesterday
- MDCE / Infinite Auctions (OTC PINK: MDCE) Delivers 2,158% Revenue Growth from Q2 and 251% Asset Growth Over Last Year, from 9:37AM ET on Thursday Nov 21, 2024 by PR Newswire
  9:37AM ET on Thursday Nov 21, 2024 by PR Newswire
  Companies Mentioned: MDCE
- MDCE / Infinite Auctions (OTC PINK: MDCE) Delivers 2,158% Revenue Growth from Q2 and 251% Asset Growth Over Last Year, from 9:37AM ET on Thursday Nov 21, 2024 by Dow Jones
  9:37AM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: MDCE
Nov 18, 2024
- NewGenIvf Obtains $100 Million Equity Line of Credit; Shares Soar Pre-Bell, from 7:45AM ET on Monday Nov 18, 2024 by MT Newswires
  7:45AM ET on Monday Nov 18, 2024 by MT Newswires
  Companies Mentioned: NIVF
- NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: NIVF
- Press Release: NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  7:00AM ET on Monday Nov 18, 2024 by Dow Jones
  Companies Mentioned: NIVF

Mainz Biomed NV
NASDAQ:MYNZUnited States
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Search Criteria

Nov 12, 2024

Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test, from 9:54AM ET on Tuesday Nov 12, 2024 by MT Newswires

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets, from 9:00AM ET on Tuesday Nov 12, 2024 by Dow Jones

Peers Headlines

Today

NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance, from 15 hours ago by Dow Jones

Yesterday

MDCE / Infinite Auctions (OTC PINK: MDCE) Delivers 2,158% Revenue Growth from Q2 and 251% Asset Growth Over Last Year, from 9:37AM ET on Thursday Nov 21, 2024 by PR Newswire

MDCE / Infinite Auctions (OTC PINK: MDCE) Delivers 2,158% Revenue Growth from Q2 and 251% Asset Growth Over Last Year, from 9:37AM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 18, 2024

NewGenIvf Obtains $100 Million Equity Line of Credit; Shares Soar Pre-Bell, from 7:45AM ET on Monday Nov 18, 2024 by MT Newswires

NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones

Press Release: NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million, from 7:00AM ET on Monday Nov 18, 2024 by Dow Jones